Jayjay Zabala Blanco, MD | |
251 E Huron St, Chicago, IL 60611-3055 | |
(312) 503-8144 | |
(310) 248-6233 |
Full Name | Jayjay Zabala Blanco |
---|---|
Gender | Male |
Speciality | Pathology - Molecular Genetic Pathology |
Location | 251 E Huron St, Chicago, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144678426 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Jayjay Zabala Blanco, MD 251 E Huron St, Chicago, IL 60611-3055 Ph: (312) 926-2000 | Jayjay Zabala Blanco, MD 251 E Huron St, Chicago, IL 60611-3055 Ph: (312) 503-8144 |
News Archive
American-Indian adolescents continue to have the highest rates of illicit drug use among all ethnic groups. Although previous research has found that increasing adolescent exposure to protective factors can reduce their risk for substance abuse, this has not been thoroughly examined in American-Indian adolescents. Recent findings from a University of Missouri study reveal that positive family relationships and religious affiliation can counteract risk factors - including addicted family members, exposure to violence and deviant peers - associated with drug use.
Hyperion Therapeutics, Inc. today announced that the first patient has been enrolled in its phase II clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate).
The Democrats outlined a new "tax trigger" as a means to overhaul the tax code. Meanwhile, news outlets reports that the two sides have largely agreed to a broad outline of spending reductions, including to Medicare and other domestic programs, but Democrats will agree to such cuts only if Republicans compromise by putting new tax revenues on the table.
The cancer drug bevacizumab (AvastinĀ®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.
› Verified 1 days ago
Mark Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611 Phone: 312-503-8144 Fax: 312-502-8249 | |
Sandeep Gurbuxani, Pathology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Katrina Krogh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St Ste 7-132i, Chicago, IL 60611 Phone: 312-926-7913 Fax: 312-926-3127 | |
Dr. Carmencita Garcia Senseng, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 W Polk St, Chicago, IL 60612 Phone: 312-864-7561 | |
Suman Setty, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jayme Brentan, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Megan Elizabeth Sullivan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-926-3211 |